Management of Meconium Aspiration with Severe RDS

Critical Initial Management

• The American Academy of Pediatrics recommends intubation and mechanical ventilation with surfactant administration for neonates with meconium aspiration and severe respiratory distress syndrome, after initial stabilization 1, 2
• Surfactant must be administered via endotracheal tube, not orally, as this is the only valid treatment route for respiratory distress 1

Surfactant Administration Protocol

• The American Academy of Pediatrics recommends rescue surfactant therapy for meconium aspiration syndrome with severe respiratory failure 2, 3

Evidence for Surfactant in MAS

• Surfactant administration in meconium aspiration syndrome improves oxygenation and reduces the need for ECMO (RR 0.64; 95% CI 0.46–0.91; number needed to treat = 6) 1, 2
• Surfactant administration in meconium aspiration syndrome does not reduce mortality (RR 0.98; 95% CI 0.41–2.39), but significantly decreases progression to ECMO requirement 1

Administration Technique

• Surfactant should be administered through an endotracheal tube as a bolus or in smaller aliquots, by clinicians with expertise in intubation and ventilator management 1, 3
• Clinicians should monitor for transient airway obstruction, oxygen desaturation, and bradycardia during surfactant administration 3

Ventilator Management

• Mechanical ventilator settings should be expeditiously adjusted after surfactant administration to prevent air leak, as lung compliance and functional residual capacity improve rapidly 1

Common Pitfalls to Avoid

• The American Academy of Pediatrics advises against attempting "oral surfactant", as this route does not exist and would be completely ineffective 1
• The American Academy of Pediatrics recommends against delaying intubation in severe RDS, as severe respiratory failure requires immediate mechanical ventilation and surfactant therapy 2, 3

Management of Severe Meconium Aspiration Syndrome

Surfactant Administration

• The American Academy of Pediatrics recommends administering rescue surfactant therapy via the endotracheal tube as a bolus or in smaller aliquots at a phospholipid dose of at least 100 mg/kg to improve oxygenation and reduce the need for ECMO in meconium aspiration syndrome with severe respiratory failure, with a relative risk of 0.64 and a number needed to treat of 6 4

Inhaled Nitric Oxide Therapy

• Inhaled nitric oxide at 20 ppm reduces the oxygenation index and increases PaO2 in neonates with hypoxic respiratory failure from meconium aspiration, with a significant reduction in the need for ECMO and the combined endpoint of death or ECMO 4